Jane Street Group, LLC Puma Biotechnology, Inc. Transaction History

Jane Street Group, LLC

$616 Billion
Q3 2025

A detailed history of Jane Street Group, LLC transactions in Puma Biotechnology, Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 138,542 shares of PBYI stock, worth $685,782. This represents 0.0% of its overall portfolio holdings.

Number of Shares

138,542

Previous 39,448 251.2%

Holding current value

$685,782

Previous $135,000 425.93%

% of portfolio

0.0%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	BUY	$3.07 - $5.73 $304,218 - $567,808	99,094 Added 251.2%	138,542 $710,000
Q2 2025 Aug 14, 2025	BUY	$2.74 - $3.72 $108,087 - $146,746	39,448 New	39,448 $135,000
Q4 2024 Feb 14, 2025	SELL	$2.42 - $3.39 $23,350 - $32,710	-9,649 Reduced 30.03%	22,480 $68,000
Q3 2024 Nov 14, 2024	BUY	$2.25 - $4.03 $36,841 - $65,987	16,374 Added 103.93%	32,129 $81,000
Q2 2024 Aug 14, 2024	SELL	$2.92 - $5.83 $1.21 Million - $2.41 Million	-413,496 Reduced 96.33%	15,755 $51,000

Q1 2024 May 15, 2024	BUY	$4.29 - $7.4 $1.25 Million - $2.16 Million	291,648 Added 211.95%	429,251 $2.28 Million
Q4 2023 Feb 14, 2024	BUY	$2.23 - $4.49 $306,854 - $617,837	137,603 New	137,603 $595,000
Q1 2023 May 15, 2023	SELL	$2.21 - $4.82 $51,097 - $111,443	-23,121 Reduced 56.64%	17,697 $54,000
Q4 2022 Feb 14, 2023	BUY	$2.12 - $5.08 $86,534 - $207,355	40,818 New	40,818 $172,000
Q2 2022 Aug 16, 2022	BUY	$1.64 - $3.3 $18,164 - $36,550	11,076 New	11,076 $32,000
Q2 2021 Aug 16, 2021	SELL	$8.98 - $11.6 $101,087 - $130,581	-11,257 Closed	0 $0
Q1 2021 May 18, 2021	SELL	$9.38 - $13.63 $383,304 - $556,976	-40,864 Reduced 78.4%	11,257 $110,000
Q4 2020 Feb 17, 2021	SELL	$7.78 - $12.13 $59,322 - $92,491	-7,625 Reduced 12.76%	52,121 $534,000
Q3 2020 Nov 17, 2020	BUY	$9.5 - $11.14 $456,598 - $535,421	48,063 Added 411.39%	59,746 $603,000
Q2 2020 Aug 17, 2020	SELL	$7.01 - $13.24 $8,271 - $15,623	-1,180 Reduced 9.17%	11,683 $122,000
Q1 2020 May 15, 2020	SELL	$6.28 - $14.57 $614,202 - $1.42 Million	-97,803 Reduced 88.38%	12,863 $109,000
Q4 2019 Feb 14, 2020	BUY	$6.5 - $10.73 $523,354 - $863,936	80,516 Added 267.05%	110,666 $968,000
Q3 2019 Nov 14, 2019	BUY	$8.75 - $12.85 $263,812 - $387,427	30,150 New	30,150 $325,000
Q2 2019 Aug 15, 2019	SELL	$12.3 - $35.76 $628,333 - $1.83 Million	-51,084 Closed	0 $0
Q1 2019 May 16, 2019	BUY	$20.77 - $42.37 $481,614 - $982,475	23,188 Added 83.12%	51,084 $1.98 Million
Q4 2018 Feb 15, 2019	BUY	$20.07 - $46.7 $219,806 - $511,458	10,952 Added 64.64%	27,896 $568,000
Q3 2018 Nov 14, 2018	BUY	$41.2 - $59.85 $145,312 - $211,090	3,527 Added 26.29%	16,944 $777,000
Q2 2018 Aug 15, 2018	BUY	$48.3 - $68.25 $648,041 - $915,710	13,417 New	13,417 $794,000
Q1 2018 May 15, 2018	SELL	$59.7 - $99.25 $811,979 - $1.35 Million	-13,601 Closed	0 $0
Q4 2017 Feb 15, 2018	SELL	$93.85 - $132.45 $158,512 - $223,708	-1,689 Reduced 11.05%	13,601 $1.34 Million
Q3 2017 Nov 14, 2017	BUY	$72.0 - $119.75 $1.1 Million - $1.83 Million	15,290	15,290 $1.83 Million

Others Institutions Holding PBYI

# of Institutions

135

Shares Held

35.2M

Call Options Held

264K

Put Options Held

View Full List

About PUMA BIOTECHNOLOGY, INC.

Ticker PBYI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,556,000
Market Cap $226M
Description
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...

More about PBYI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Account

Jane Street Group, LLC Puma Biotechnology, Inc. Transaction History